| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |